News for Catalent, Inc. (0C8.F)

Vancouver, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- The global prefilled syringes market is projected to gain USD 9.11 billion by 2027 at a ...

Read more about J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators on Business Standard. (Reuters) - Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is contingent on

Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,... | February 19, 2021

Daniel Loeb's Top Trades of the 4th Quarter, Stocks: UPST,GOOGL,FTV,BABA,INTU,APTV,SWK,NKE,CTLT,LESL, Daniel Loeb, release date:Feb 18, 2021

Daniel Loeb's Top Trades of the 4th Quarter, Stocks: UPST,GOOGL,FTV,BABA,INTU,APTV,SWK,NKE,CTLT,LESL, Daniel Loeb, release date:Feb 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) 10X ...

Regional Sites China Japan Latin America ... | February 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 2) Argenx ...

A strong finish on Wall Street may encourage another ‘risk-on’ session across Asia-Pacific markets. Upbeat earnings from Alphabet, Amazon and Alibaba set a favourable tone for the tech-led rally.

Stocks that traded heavily or had substantial price changes Tuesday: Uber, UPS rise; Vertex Pharmaceuticals, BP fall

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 1) Abbott ...

Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick started, with Novartis ...

Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick started, with No...

AstraZeneca’s CEO promised more shots, at a lower price, than competitors, but now faces criticism from the EU for a production shortfall.

AstraZeneca’s CEO promised more shots, at a lower price, than competitors, but now faces criticism from the EU for a production shortfall.

Gosselies, Belgium, 20 January 2021, 7am CET - BONE THERAPEUTICS , the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today provides a business... | January 20, 2021

Today's Daily Dose brings you news about Acorda's restructuring; Alexion's decision to pause its COVID-19 trial; and analyst's rating on Synlogic..

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) ...